INTRODUCTION
The food safety, biomedical research and environmental monitoring areas require methods of screening with the ability to detect, rapidly and sensitively, trace amount of small targets (<1000 Da). As an example, Anabolic Androgenic Steroids (AAS) are completely prohibited substances by the WADA (World Antidoping Agency) (1) and the European Community (2), for their respective use to improve athletic performance and to increase meat production in the agro-alimentary field, due to the associated adverse health effects.
Immunosensors based on the surface plasmon resonance (SPR) principle provide a rapid and convenient analytical alternative for monitoring (bio)chemical substances in a labelfree way (3) (4) (5) (6) (7) (8) (9) . Several strategies have been used to anchor the immunoreagents onto gold chips to develop SPR biosensors to detect small molecules under competitive immunochemical configurations. In indirect formats, usually a protein functionalized with the hapten is immobilized on the surface of the transducer (10-12) however; alternative methods to avoid the use of a carrier protein have been described. For example, an oligo(ethyleneglycol) (OEG) linker was used on a SPR biosensor to detect 2,4,6-trinitrotoluene (TNT) (13) and testosterone (14) . In direct detection formats, the antibody can be immobilized directly through a self-assembled layer (SAM) of heterobifunctional linkers possessing a thiol group, although alternative methods to appropriately orientate the antibody molecule have also been described. Thus, it has been reported the immobilization of antibodies by affinity interaction with a layer of protein A previously immobilized on the gold substrate (15). Moreover, the use of DNA-protein conjugates has also been reported on nanoscale immunosensors microstructured biochips (16). Hence, a protein G-DNA conjugate has been employed to ensure controlled immobilization of antibodies to intended areas of a chip surface or to particles (17). The DNA-directed immobilization (DDI) strategy provides a chemically mild process for the simultaneous binding of multiple proteins to a solid support using DNA surfaces as immobilization matrices. It consists on tagging biomolecules with oligonucleotides chains that are complementary to ssDNA previously linked on the surface. An additional advantage of this strategy is the possibility to produce regenerable sensor surfaces due to the reversible nature of the DNA hybridization reaction. This strategy has been used to immobilize antibodies covalently linked to ssDNA onto a SPR surface where the complementary strands have been previously immobilized, to detect three fertility hormones in a direct competitive format (18, 19) . However, this approach has been rarely used to immobilize haptens on a SPR gold chip. Previously, we have demonstrated the possibility to use DDI to create hapten microarrays for fluorescent detection (20) . This time, our objective has been to demonstrate the biofunctionality of steroid-oligonucleotide bioconjugates synthesized and characterized to use them on a SPR biosensor and to assess the possibility to develop multiplexed SPR immunosensors for small organic molecules by directly immobilizing the haptens on the gold chip through a DDI approach (12, (22) (23) (24) (25) (26) (27) .
haptens (8, hG and 13, respectively) and the production of the antiserums (As147, As170 and As138, respectively) has been described previously (28) (29) (30) . N,N'-dicyclohexylcarbodiimide 99% (DCC) was purchased from Aldrich and the Nhydroxysuccinimide (NHS) from Fluka. Benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluorophosphate (PyBOP) was from Bachem (Bachem, Switzerland). Long chain alkylamine Controlled Pore Glass (LCAA-CPG) was from CPG (CPG Inc., New Jersey, USA).
Instrumentation
Oligonucleotide sequences were synthesized on an Applied Biosystems DNA synthesizer model 3400 (Applied Biosystems, USA). Mass spectra (matrix-assisted laser desorption ionization time-of-flight, MALDI-TOF) were provided by the Mass Spectrometry service of the University of Barcelona. UV-Visible spectra were recorded on a Shimadzu UV-2101PC spectrophotometer. HPLC (SHIMADZU-9A) with manual injector volume of 150 µL, bomb LC-9A and detector SPD-M6A UV-VIS.
Commercial SPR chips with bare gold surface, SPRchip ™ and spotReady™ (GWC Technologies, USA) substrates, were used for all the experiments. Imaging SPR measurements were collected with a GWC Technologies SPR Imager II instrument (GWC Technologies, USA). Measurements were performed at a fixed angle of incidence collecting the changes on the reflected light intensity through imaging the SPR chip with a CCD camera. The spotReady™ chips contain an array of gold spots where positive and negative controls can be included and measured simultaneously. Individual chips were index-matched to the prism and fitted with a 20 µl flow cell connected to a peristaltic pump from Ismatec (Glattbrugg, Switzerland). A total volume of 0.5 mL was needed to completely fill the tubing and flow cell with buffer or analyte. The SPR images were collected and analyzed using V ++ software (Digital Optics, New Zeland).
Synthesis and purification of oligonucleotides and steroid-oligonucleotide conjugates
Three pairs of oligonucleotide complementary sequences were designed (see Table 1 ).
Three oligonucleotides were prepared with an amino group at the 5'-end (N 1 up, N 2 up and 
2) Synthesis of oligonucleotides carrying steroids using the solid-phase coupling protocol
The oligonucleotide sequences carrying an amino group at the 5'-end were prepared as The fractions containing oligonucleotide were analyzed by HPLC-UV as described above.
The desired steroid-oligonucleotide conjugates eluted at around 11 min, and were obtained with global yields of 52% for 8-N 1 up and 40% for hG-N 2 up. Finally, the conjugates were characterized by UV and mass spectrometry (MALDI-TOF). MALDI-TOF m/z (negative mode) 8-N 1 up, calc 6668, found 6672; hG-N 2 up, calc 6619, found 6614. In this last compound we also observed a second peak at 6333 m/z corresponding to the hapten fragmentation at the oxime bond.
DNA site-encoded SPR immunosensor
General considerations. All the SPR experiments began with a buffer baseline (10mM PBS with 100 mM NaCl, assay buffer) and the same buffer was used to wash between each step and to prepare all the solutions of the bioreagents. All the solutions were flowed at a rate of 3 µL·s 
RESULTS AND DISCUSSION

Synthesis and purification of steroid-oligonucleotide conjugates
A set of three complementary pairs of ssDNA (N 1 , N 2 and N 3 , up and down) were synthesized. These sequences have 50% G:C content (purines/pyrimidines) and have the same composition but different sequence. In this way it is expected that the three resulting duplexes will have similar hybridization properties. The sequences should display high hybridization efficiency for maximum hapten density at the surface after the immobilization. The specificity of the hybridization of these sequences has been previously studied in our group in a microarray multiplexed competitive format (20) and the results indicated hardly any cross-hybridization between the three sequences.
Once a complete set of oligonucleotides sequences were chosen, the steroid-oligonucleotide conjugates were prepared. The synthesis of oligonucleotides carrying steroids such as cholesterol (32, 33) , hydroxyprogesterone (34), dexamethasone (35) , digoxigenin (36), cholic (37), lithocholic (38) and bile acids (39) have been described in order to obtain hydrophobic derivatives of oligonucleotides for antisense, triplex and RNA interference studies (40) . Most of these compounds are synthesized by conjugation of carboxylic acid derivatives to oligonucleotide carrying amino groups although the direct incorporation to oligonucleotides using the corresponding phosphoramidites have also been described for compounds that can be prepared in large amounts (32) (33) (34) . In our case the amount of carboxylic acid derivatives available was low so post-synthetic methods were selected.
Thus, ST, THG and B steroid-oligonucleotides conjugates were prepared through the formation of amide bonds (see Table 1 ). The steroidal haptens used in these conjugations have been previously used to develop enzyme linked immunosorbent assays (ELISAs) to detect AAS in real samples (28) (29) (30) .
The conjugation of boldenone hapten (13) to amino-oligonucleotide N 3 up was performed with the unprotected amino-oligonucleotide in aqueous solution. The hapten 13 has an ester group which in basic medium could be hydrolyzed. For this reason conjugation was not possible before ammonia deprotection. Therefore, we used the solution-phase coupling to obtain the desired conjugate 13-N 3 up (B) in 20-30% yield ( Figure S2 , supporting information). The NHS-ester of 13 was prepared by reaction of the carboxylate moiety with NHS using DCC (41) . Increasing the molar excess of active ester from 10 to 30 times excess, allows the conversion of the amino-oligonucleotide to the desired conjugate to 45%
( Figure S2, supporting information) .. The mass obtained for this conjugated was 6400 m/z while the mass expected was 6639 m/z. We attribute this difference at the fact that during MALDI-TOF analysis fragmentation can occur as a result of heating (laser ionization) in the acidic environment (the matrix) and then what we could observe is the oligonucleotide with the steroid attached hydrolyzed at the ester point. This was confirmed by using electrospray MS analysis. The softer ionization conditions provided the expected mass (13-N 3 up, calc 6639, found 6639).
On the other hand, it had been also reported that solid phase synthesis may be advantageous to the standard synthesis in solution (42) In order to assess the influence of the steroids in the duplex structure denaturation curves were analyzed. Table S1 (supplementary information) shows the melting temperatures of duplexes carrying the steroids stanozolol (8), tetrahydrogestrinone (hG), and boldenone (13). As expected, the presence of the steroid at the 5'-end of the duplex has very little effect in the stability of the duplex.
The recognition of the oligonucleotide-steroid conjugates by specific antibodies was analyzed by immobilization of the duplex DNA carrying steroids on glass surfaces followed by incubation with the specific antisera and the visualization of the antigenantibody interaction with a fluorescently labeled anti-rabbit secondary antibody as described previously [20] . The presence of the oligonucleotides chain does not affect to the recognition of antigen antibody as it can be observed in the detectability parameters (LOD and IC 50 ) in the table S2 in the supplementary material.
Evaluation by SPR of the biofunctionality of the steroid-oligonucleotide conjugates
Hybridization. The specificity of the hybridization step was assessed by SPR by flowing Table 1 , it can be observed that the sequence of the oligonucleotide N 1 down at the 5'-end has CAG whereas in the sequences N 2 down and N 3 down, in both cases we have CGG. Therefore, changes in the conductimetric properties of the double helix, could affect the refractive index and influence in the SPR signal (46, 47) .
Immunochemical recognition. Three specific antisera (As147, As170 and As138, 1/250 dilution) and a non-specific serum (CTR-NEG) were used to test if after the conjugation of the steroids with the oligonucleotides chains, the antibodies could still recognize their corresponding steroidal haptens. The features of these antibodies have been previously described (28) (29) (30) . Results presented in the Figure 3 and Figure S1 Figure 3) is due to the distinct antisera affinity for the corresponding steroid-oligonucleotide conjugates. And another remarkable fact is the complete regeneration of the surface with a simple washing step with diluted NaOH solution, which offers to these chips the possibility to be reused. 
